Cargando…
Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745
Autores principales: | van de Velde, Mirjam Esther, Kaspers, Gertjan J. L., Abbink, Floor C. H., Twisk, Jos W. R., van der Sluis, Inge M., van den Bos, Cor, van den Heuvel-Eibrink, Marry M., Segers, Heidi, Chantrain, Christophe, van der Werff ten Bosch, Jutte, Willems, Leen, van den Berg, Marleen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000134/ https://www.ncbi.nlm.nih.gov/pubmed/36900422 http://dx.doi.org/10.3390/cancers15051359 |
Ejemplares similares
-
Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial)
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020) -
Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)
por: Uittenboogaard, Aniek, et al.
Publicado: (2023) -
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022) -
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer
por: van de Velde, Mirjam E., et al.
Publicado: (2021) -
Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)